Heart Failure

The U.S. Food and Drug Administration (FDA) approved Amgen’s ivabradine (Corlanor) to reduce hospitalization from worsening heart failure.

Results of a clinical trial announced at the American College of Cardiology Annual Scientific Session show a new type of therapy is safe and effective for symptomatic advanced heart failure patients already receiving optimum drug and dev...

CardioMEMS, heart failure, ACC.15, ACC 2015, Champion trial

Heart failure patients with reduced ejection fraction experienced significant HF mortality and hospitalization reductions via guideline-directed medical therapy managed by pulmonary artery pressure monitoring with the CardioMEMS HF System, accordi...

ICDs, battery life, advances in implantable cardioverter defibrillators

There have been several recent advancements in implantable cardioverter defibrillator (ICD) technology to extend battery life, improvements in patient monitoring to avoid needless shocks, the introduction of quadripolar lead devices to improve dev...

Philips introduced CareSage at HIMSS 2015, which is new predictive analytics engine that enables health systems to better monitor and care for elderly patients...
Penn Medicine, congestive heart failure, readmissions, Health Recovery Solutions
Penn Medicine’s Penn Care at Home program reported a 53 percent reduction in 30-day readmission rates for 130 congestive heart failure patients since...
EBR Systems Inc. announced it has raised $20 million for clinical studies and regulatory filings, including commitments toward a second quarter closing. EBR...
Cerner, Qualcomm, home health monitoring, 2net, CareAware, EHR
Cerner Corp. and Qualcomm Life Inc. announced an agreement to extend Cerner’s medical device connectivity capabilities beyond the hospital to the home. Cerner...
The HD Medical Inc. ViScope visual stethoscope product family provides dynamic auscultation — the ability to see what you hear. ViScope’s...
Cerner Corp. and Qualcomm Life Inc. announced an agreement to extend Cerner’s medical device connectivity capabilities beyond the hospital...
The latest version of the AliveECG app from AliveCor Inc. instantly detects when an electrocardiogram (ECG) is either normal or unreadable...

Articles

ivabradine (Corlanor)
The U.S. Food and Drug Administration (FDA) approved Amgen’s ivabradine (Corlanor) to reduce hospitalization from worsening heart failure.
catheter ablation, Afib, Amiodarone, Luigi Di Biase, ACC, heart failure
Patients with heart failure and atrial fibrillation were less likely to experience death, hospitalization or recurrent Afib with catheter ablation than with a...
Bendavia, heart attack, scarring, angioplasty, ACC, study
Patients who received the new drug Bendavia before undergoing angioplasty or stent implantation after a heart attack showed no significant reduction in...
heart failure, BAT, baroreflex activation therapy, William Abraham, CVRx
Results of a clinical trial announced at the American College of Cardiology Annual Scientific Session show a new type of therapy is safe and...

Video Center

U.S. healthcare reform is largely being driven through adoption of new information technology (IT...
2 days 9 hours ago
The biggest technology news coming out of the 2015 American College of Cardiology (ACC) annual...
4 weeks 2 days ago
It’s been no secret that the American healthcare system needed to change to survive economically...
10 weeks 2 days ago
Centricity, webinar, ZFV, ZFP, viewer, remote viewing system, enterprise
Healthcare organizations are demanding more capabilities for image viewers accessed by clinicians. Zero footprint (ZFP) viewers provide imaging tools from...
The webinar "State of the Art in MRI Pediatric Brain Perfusion Imaging" educates participants about the state of the art clinical and emerging translational...
This webinar discusses why contemporary adult cardiac interventions require significant ionizing radiation with potential health risks to both the patient and...

Comparison Charts

Sorry there is no data available